Abstract
In the current scenario, discovery of natural bioactive components can be considered as a
major development in treating common ailments. One of the medicinally important herbs is Murraya
koenigii. The biological functions are promoted by the leaves, fruits, roots, and bark of this beautiful
plant. It is the carbazole alkaloids that promote most of the medicinal properties and contribute to the
anti-oxidative properties as well. Terpenoids, Flavonoids, Saponins and Phenols isolated from different
parts of the plant have unique hypocholestrolemic and antidiabetic activities. Among commonly
used alternative therapies, plant sterols present in M. koenigii may help to reduce cholesterol and
triglyceride levels, in turn managing heart diseases. Experimental animal studies are proving the hypolipidemic
ability of M. koenigii. Possible mechanisms involved in exhibiting such an amazing hypolipidemic
ability can be attributed to the phytochemicals, some of which can reduce the absorption
of cholesterol in the intestines or accelerate the catabolism of fats. In contrast, others can inhibit the
enzyme HMG CoA reductase. M. koenigii can inhibit pancreatic lipase. Such a response could be
due to the presence of carbazole alkaloids like Mahanimbin, Isomahanine, Murrayacinine,
Koenimbine, Mahanimboline, Murrayazolinine, Girinimbine etc. These enzymes can be selected for
the pharmaceutical mediation of hypocholesterolemia agents. A triumph over the production of lipids
in the hepatic cells is achieved upon feeding M. koenigii, thereby bringing about a drastic fall in
triglyceride levels. The present review provides a better understanding of the major components of
M. koenigii against dyslipidemia that could serve as an herbal alternative while treating other pathological
conditions. Although various extracts of M. koenigii have numerous medical applications, an
extensive investigation of their toxicity, along with more clinical trials and standardization of protocols,
is required to produce modern drugs from these leaf extracts.
[3]
Kant Upadhyay R. Antihyperlipidemic and cardioprotective effects of plant natural products: A review. Int J Green Pharm 2021; 15(1): 11.
[5]
Mhaskar KS, Blatter E, Caius JF. Kirtikar and Basu’s Illustrated Indian Medicinal Plants: Their Usage in Ayurveda and Unani Medicines. Sri Satguru Publications 2000; 10.
[6]
Chaudhary A. A review on the culinary uses and therapeutic properties of murraya koenigii. J Adv Pharmacogn 2020; 1(1)
[7]
Igara C, Omoboyowa D, Ahuchaogu A, Orji N, Ndukwe M. Phytochemical and nutritional profile of Murraya koenigii (Linn) Spreng leaf CE Igara, DA Omoboyowa, AA Ahuchaogu, NU Orji and MK Ndukwe. J Pharmacogn Phytochem 2016; 5(5): 4-7.
[9]
Prakash PN and Natarajan CP. Studies on curry leaf (Murraya koenigii L). J Food Sci Technol 1974.
[10]
Vinuthan MK, Kumar VG, Ravindra JP, Gupta PSP, Arun SJ. Changes in the blood lipid profile after administration of Murraya koenigii Spreng (curry leaf) extracts in the normal Sprague Dawley rats. Indian J Anim Res 2007; 41(3): 223-5.
[15]
Molly J. Effect of Murraya koenigii (curry leaves) powder on the liver and renal functions in women with hyperlipidemia. Int J Health Sci Res 2017; 7(1): 188-92.
[16]
Khan BP, Abraham A, Leelamma S. Biochemical response in rats to the addition of curry leaf (Murraya koenigii) and mustard seeds (Brassica juncea) to the diet. Plant Foods Hum Nutr 1996; 49(4): 295-9.
[25]
Isolated P. NPC. Nat Prod Commun 2010; 1(4): 9-12.
[27]
Handral H. Pharmacophore 2010; (April): 2016.
[29]
Tanaka CUY. NII-electronic library service. Chem Pharm Bull 1994; 17(11): 1460-2.
[32]
PATRICK S. ChemInform Abstract: THE DI-PI-methane rearrangement, stereochemistry. Chem Informat 1974; 5(11)
[33]
Reisch J. Alkaloids from seeds of murraya koeivzgzz. 1992; 31(8): 2877-9.
[36]
Boccellino M, Angelo S D. Anti-obesity effects of polyphenol intake: Current status and future possibilities. Int J Mol Sci 2020; 21(61): 5642.
[40]
Gupta S, Paarakh PM, Gavani U. Antioxidant activity of murraya koenigii linn leaves. Pharmacologyonline 2009; 478: 474-8.
[47]
Ashokkumar K, Selvaraj K, Devi S. Reverse phase-high performance liquid chromatography-diode array detector (RP-HPLC-DAD) analysis of flavonoids profile from curry leaf (Murraya koenigii. L). J Med Plants Res 2013; 7(47): 3393-99.
[48]
Saad B, Ghareeb B, Kmail A. Metabolic and epigenetics action mechanisms of antiobesity medicinal plants and phytochemicals. Evid-Based Complemen Altern Med 2021; 2021: 19.
[53]
Elekofehinti OO. The effect of saponin from solanum anguivilam. Fruit on serum lipid and oxidative stress in hepatocyte of diabetic rats. Brazillian conference of medicinal plants. Bentos Goncalves, Brazil. 2014; pp. 3-5.
[54]
Tomar RS, Banerjee S, Kaushik S. Assessment of antioxidant activity of leaves of Murraya koenigii extracts and it’s comparative efficacy analysis in different solvents. J Pharm Sci Res 2017; 9(3): 288-91.
[62]
Kejariwal M. Antioxidant potential of Murraya koenigii‘s ( L .) Sprenge polysaccharide. Bull Env Pharmacol Life Sci 2021; 10(1): 98-105.